190 related articles for article (PubMed ID: 26198807)
1. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
;
Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
[TBL] [Abstract][Full Text] [Related]
2. The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE;
Am J Ophthalmol; 2018 Nov; 195():101-109. PubMed ID: 30081012
[TBL] [Abstract][Full Text] [Related]
3. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.
Kupersmith MJ; Sibony PA; Feldon SE; Wang JK; Garvin M; Kardon R;
Am J Ophthalmol; 2017 Apr; 176():77-86. PubMed ID: 28040526
[TBL] [Abstract][Full Text] [Related]
5. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith M; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8180-8. PubMed ID: 25370510
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
Albrecht P; Blasberg C; Ringelstein M; Müller AK; Finis D; Guthoff R; Kadas EM; Lagreze W; Aktas O; Hartung HP; Paul F; Brandt AU; Methner A
J Neurol; 2017 Jul; 264(7):1370-1380. PubMed ID: 28584914
[TBL] [Abstract][Full Text] [Related]
7. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Wall M; Thurtell MJ;
Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
[TBL] [Abstract][Full Text] [Related]
8. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
[TBL] [Abstract][Full Text] [Related]
9. Retinal vessel diameter changes after 6 months of treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
Moss HE; Hollar RA; Fischer WS; Feldon SE
Br J Ophthalmol; 2020 Oct; 104(10):1430-1434. PubMed ID: 31949093
[TBL] [Abstract][Full Text] [Related]
10. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
[TBL] [Abstract][Full Text] [Related]
11. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension.
Dreesbach M; Joachimsen L; Küchlin S; Reich M; Gross NJ; Brandt AU; Schuchardt F; Harloff A; Böhringer D; Lagrèze WA
Transl Vis Sci Technol; 2020 Feb; 9(3):24. PubMed ID: 32742754
[TBL] [Abstract][Full Text] [Related]
12. Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
Wang JK; Kardon RH; Ledolter J; Sibony PA; Kupersmith MJ; Garvin MK;
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2554-2565. PubMed ID: 28492874
[TBL] [Abstract][Full Text] [Related]
13. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
Dinkin MJ; Patsalides A
J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
[TBL] [Abstract][Full Text] [Related]
14. Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension.
Aojula A; Mollan SP; Horsburgh J; Yiangou A; Markey KA; Mitchell JL; Scotton WJ; Keane PA; Sinclair AJ
BMC Ophthalmol; 2018 Jan; 17(1):257. PubMed ID: 29298687
[TBL] [Abstract][Full Text] [Related]
15. Correlation Between Optic Disc Peripapillary Capillary Network and Papilledema Grading in Patients With Idiopathic Intracranial Hypertension: A Study of Optical Coherence Tomography Angiography.
Rodriguez Torres Y; Lee P; Mihlstin M; Tomsak RL
J Neuroophthalmol; 2021 Mar; 41(1):48-53. PubMed ID: 31972713
[TBL] [Abstract][Full Text] [Related]
16. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.
Rebolleda G; Muñoz-Negrete FJ
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5197-200. PubMed ID: 19011007
[TBL] [Abstract][Full Text] [Related]
17. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.
Gospe SM; Bhatti MT; El-Dairi MA
Br J Ophthalmol; 2016 Apr; 100(4):505-9. PubMed ID: 26269534
[TBL] [Abstract][Full Text] [Related]
18. Retinal nerve fiber layer thickness analysis in cases of papilledema using optical coherence tomography – A case control study.
Ahuja S; Anand D; Dutta TK; Roopesh Kumar VR; Kar SS
Clin Neurol Neurosurg; 2015 Sep; 136():95-9. PubMed ID: 26093225
[TBL] [Abstract][Full Text] [Related]
19. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography.
Wang JK; Kardon RH; Kupersmith MJ; Garvin MK
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4069-75. PubMed ID: 22599584
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.
Skau M; Yri H; Sander B; Gerds TA; Milea D; Jensen R
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):567-74. PubMed ID: 22592348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
